Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.

@article{Tesa2015CorticosteroidsII,
  title={Corticosteroids in IgA Nephropathy: A Retrospective Analysis from the VALIGA Study.},
  author={Vladim{\'i}r Tesař and St{\'e}phan Troyanov and Shubha S Bellur and Jacobien C Verhave and H Terence Cook and John Feehally and Ian S D Roberts and Daniel C. Cattran and Rosanna Coppo},
  journal={Journal of the American Society of Nephrology : JASN},
  year={2015},
  volume={26 9},
  pages={2248-58}
}
Current guidelines suggest treatment with corticosteroids (CS) in IgA nephropathy (IgAN) when proteinuria is persistently ≥1 g/d despite 3-6 months of supportive care and when eGFR is >50 ml/min per 1.73 m(2). Whether the benefits of this treatment extend to patients with an eGFR≤50 ml/min per 1.73 m(2), other levels of proteinuria, or different renal pathologic lesions remains unknown. We retrospectively studied 1147 patients with IgAN from the European Validation Study of the Oxford… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 37 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 31 references

Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations andtreatments

  • M Praga, S Feriozzi, +9 authors F Ferrario
  • 2014

Similar Papers

Loading similar papers…